search
Back to results

UM CRMC RecuR Score Pilot

Primary Purpose

Patient Readmission, Pulmonary Disease, Chronic Obstructive, Heart Failure

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard of Care
Enhanced Care
Sponsored by
University of Maryland, Baltimore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Patient Readmission focused on measuring patient, unplanned, hospital, readmissions

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria Patient is in Observation (and is expected to be admitted) or is admitted as an Inpatient Encounter. Consider eligible patients in any unit except Emergency Department. Patient has RecuR Score available 24 hours after start of data collection in EHR. Patient is at least 18 years of age. Participant is willing and able to provide informed consent for the trial. Participant has a RecuR Score greater than or equal to 3; OR Participant has a RecuR Score greater than or equal to 2 and length of stay greater than 10 days; OR Participant has a RecuR Score greater than or equal to 2 with admitting diagnosis of COPD, CHF, Diabetes with elevated HbA1c, Hypertension, or pneumonia; OR Participant has any RecuR Score AND current admission is a readmission where participant was not enrolled during any prior admission. Exclusion Criteria Patients who were enrolled in the pilot during an earlier inpatient hospital encounter. Patients with encounters having length of stay less than 48 hours or greater than 30 days. Patients who are not expected to be discharged to "home", e.g., patients who were admitted from skilled nursing facility (SNF) and are expected to be discharged to SNF. Use Admission Source (or disposition field) as an indicator of who may not be discharged home. Patients with an admission diagnosis of Septicemia. Patients who lack capacity to sign the consent and participate in the study. Patients who are not fluent English. Patients who are already receiving home health care. Patients who the nursing team believes will require home health care post- hospitalization. Post-Hoc Exclusion Criteria • Patients who leave against medical advice.

Sites / Locations

  • University of Maryland Charles Regional Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Arm 1: Intervention A

Arm 2: Receives Intervention "A" and Intervention "B"

Arm Description

Diagnosis education includes verbal 1:1 patient education by the Transitional Nurse Navigator (TNN) and a folder with Epic printed education and other handouts specific to that disease process. Follow-up appointment scheduling assistance, including transportation to the follow-up appointment. The Community Health Worker (CHW) or TNN will schedule the appointments for the PCP and other specialists within 1 week when available. Offer resources in the community post the 1:1 meeting with the patient to meet specific access to care challenges identified for that patient by the TNN or CHW. Provide weekly follow-up calls for one month by TNN or delegate. Social Determinants of Health (SDOH) assessment. Screenings by CHW regarding patients' SDOH and documentation in the EHR (Epic) of this SDOH assessment. If a patient demonstrates a need, a CHW will help identify and offer opportunities for the patient.

Additional educational training using iPads. Education using iPad and/or teach-back components to reinforce the individualized disease and medication specific education. iPads are programmed with patient education from "The Patient Channel." This visit will be completed by a TNN. Focus on readmission risk during Care Transition Rounds. Multi-disciplinary team conducts daily rounds to discuss patient. TNNs share the risk scores for the patients and discuss coordination of the patient receiving interventions and other resources suggested by team members. Home health care from Home Health Services (HHS), Mobile Integrated Healthcare (MIH) or Resources, Education and Access to Community Health (REACH). Involves home visits to the patient, environmental assessments, and medication reconciliation from a home health nurse. Duration and specifications of home health care depend on the patient's needs. Participants will be assigned based on program eligibility and availability.

Outcomes

Primary Outcome Measures

Number of overall participants with 30-day post-discharge hospital readmission
This is the first primary endpoint of this fallback design study. It measures the number of participants with a hospital readmission in the 30 days post-hospital discharge in the overall study population.
Number of moderate-high risk participants with 30-day post-discharge hospital readmission
This is the second primary endpoint of this fallback design study. It measures the number of moderate-high risk participants, those having a RecuR Score of 2 or 3, with a hospital readmission in the 30 days post-hospital discharge.

Secondary Outcome Measures

30 day post-discharge mortality
Number of participants with 30 day post-discharge mortality
30 day post-discharge unplanned hospital readmission
Number of participants with 30 day post-discharge unplanned hospital readmission
90-day post-discharge unplanned hospital readmission
Number of participants with 90 day post-discharge unplanned hospital readmission
30-day post-discharge emergency department usage
Number of participants with 30 day post-discharge emergency department usage
90-day post-discharge emergency department usage
Number of participants with 90 day post-discharge emergency department usage

Full Information

First Posted
March 1, 2023
Last Updated
August 14, 2023
Sponsor
University of Maryland, Baltimore
Collaborators
University of Maryland Medical System
search

1. Study Identification

Unique Protocol Identification Number
NCT05765903
Brief Title
UM CRMC RecuR Score Pilot
Official Title
Readmission Risk Score (RecuR Score) Pilot at The University of Maryland Charles Regional Medical Center (UM CRMC)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 2023 (Anticipated)
Primary Completion Date
September 2026 (Anticipated)
Study Completion Date
September 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
Collaborators
University of Maryland Medical System

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will look to implement a plan for enhanced transitional care for patients at high risk of unplanned hospital readmission in hopes of reducing their risk for readmission in the first 30 days post discharge from an inpatient encounter. Hospital readmissions are an undesirable occurrence that can increase cost for hospitals, and can cause further negative outcomes for patients. Identifying factors that increase a patient's chances of being readmitted to the hospital, as well as developing an intervention to effectively reduce this risk, has historically been challenging. Our new method uses a combination of common features such as diagnosis and length of hospital stay, with a novel artificial intelligence (AI) algorithm, the RecuR Score model developed by the University of Maryland Medical System, that identifies patients at the highest risk of having an unplanned hospital readmission. Participants identified as higher risk will then be enrolled into our pilot where they will be randomized to receive either the standard of care treatment or an enhanced protocol that includes additional disease education, coordination of home health services, and a focus on their readmission during existing multidisciplinary team huddles. The main goal of this study is to reduce unplanned hospital readmission within 30 days of initial discharge, in those most at risk of being readmitted, using the aforementioned novel methods for identifying these participants and a transitional care intervention. This success of this goal will be analyzed across different readmission risk levels in the study population. Secondary goals of this study include reducing unplanned hospital readmission within 90 days, reducing 30-day post-discharge mortality, and reducing 30- and 90-day emergency department (ED) usage after an initial hospitalization.
Detailed Description
BACKGROUND Hospital readmission is an adverse health outcome that incurs significant cost to the healthcare ecosystem. While undesired, unplanned hospital readmission within 30 days of discharge is not uncommon. To improve care quality and reduce unnecessary healthcare costs, in 2013, the Center for Medicare and Medicaid Services (CMS) launched the Hospital Readmissions Reduction Program (HRRP) as part of the Value Based Purchasing (VBP) program to encourage better discharge care coordination. Under the HRRP program, hospitals with high readmission rate incur a payment reduction of up to 3 percent. Since the launch of the HRRP program, reducing hospital readmissions has elevated to a strategic priority of hospitals. Best practices to effectively reduce hospital readmissions while maintaining a healthy operating margin are sought after by hospitals across the country. Studies on most optimal intervention structure and intensity have yet to identify a single effective strategy, and the effectiveness and external validity of interventions in the literature remains uncertain. Across all patients at University of Maryland Charles Regional Medical Center (UM CRMC) between January 2019 and January 2022, the unplanned hospital readmission rate was 11% and this value is as high as 30% across certain highest risk groups. UM CRMC has implemented a Transitional Care Program with Nurse Navigators since 2011 that focuses on patients that are typically known to have a higher rate of readmission (patients whose primary reason for admission is Diabetes, Congestive Heart Failure [CHF], Chronic Obstructive Pulmonary Disease [COPD] and Hypertension). Despite genuine efforts to manage these patients and provide additional support to these patients prior to discharge and post-discharge, the readmission rate at UM CRMC has remained relatively unchanged over the past five years between 7-15% (mean 11% ± 1.5%) with no sustained year-over-year improvement. At the University of Maryland Medical System (UMMS), we have developed an artificial intelligence (AI)-powered risk score called the RecuR Score (Readmission Risk Score). The RecuR Score estimates the risk of 30-day unplanned readmission for patients both in-house and during the 30 days after inpatient discharge. Patients are grouped in one of five score levels (1-5), where a RecuR Score of 1 indicates the lowest risk of readmission and a RecuR Score of 5 indicates the highest risk of readmission. This risk score is retrained monthly using data from patients with encounters at UMMS hospitals. The target population is inpatients, currently in-house non-inpatients (Emergency Department, Observation Unit) who might become inpatients, and previous inpatients within 30 days of discharge. The score uses data from the UMMS electronic health record system (EHR), CRISP (Chesapeake Regional Information System for our Patients - the state-designated Health Information Exchange for Maryland), commercial and non-commercial claims, and the U.S. Census Bureau. A comparison of the performance of the RecuR Score compared to LACE and HOSPITAL on the same patients showed that the Area Under the Receiver Operating Characteristic Curve, sometimes known as the Area Under the Curve (AUC), of the RecuR Score significantly outperforms the other two metrics, even prior to discharge. While LACE is only available at discharge, HOSPITAL is described as most accurate at discharge, and even then, it is outperformed by the RecuR Score at 48 hours post-arrival when the RecuR Score is not at its best The literature review shows that efforts to reduce readmission rates are not consistently effective, and it has been difficult to extract a set of interventions that reliably reduces readmissions. Our team theorizes that efforts to reduce readmission rates are not effective because the patients are not adequately stratified into risk categories resulting in interventions not being used on the patients who will benefit the most from the interventions. This pilot addresses this issue by identifying patients at higher risk of readmission using the RecuR Score. The RecuR Score accurately identifies patients at high risk of readmission with an area under the ROC curve of 0.83. This higher risk population (limited to selected principal diagnoses and other inclusion and exclusion criteria) has a higher readmission rate (19.4%) than the hospital's overall readmission rate (11%), which results in a greater opportunity to reduce the readmission rate for the target population. To address the issue of identifying the most effective interventions, our team also theorizes that the interventions used are not robust, meaning that the impact of the intervention is insufficient. For example, most readmission intervention programs focus on phone calls post-discharge without considering a more complete view of the patient's situation. To address this issue, this pilot is implementing more complex interventions such as additional educational materials, a focus on the patient's readmission risk during interdisciplinary medical team huddles/care transition rounds, and multiple home healthcare programs that cover a broad spectrum of potential interventions. The expectation is that by accurately identifying the higher risk patients and having a broader view of the patients' situation with multiple interventions, we can reduce the 30-day unplanned readmission rate. STUDY OBJECTIVES Offering more complex interventions that are higher intensity than those currently universally provided at UM CRMC. By targeting patients who are at a higher risk of readmission using a novel AI-based risk score, the RecuR Score, resources can be best allocated to those who need them most. These more intense interventions include additional educational materials, emphasis on a patient's readmission risk during their multidisciplinary team huddle, and home health services. For the study, we will only be targeting patients with a high readmission risk (based on the patient's RecuR Score), to test the efficacy of the standardized use of these resources. The first primary hypothesis for this study is that using a novel UMMS algorithm (RecuR Score) to identify patients at a higher risk of unplanned hospital readmission combined with enhanced pre-discharge and follow-up care interventions including, additional educational material about their health, a focus on their readmission risk during interdisciplinary team huddles, and home health care, can reduce 30-day unplanned hospital readmissions in this high-risk group by 30%. The second primary hypothesis in this fallback design trial, is that using the aforementioned enhanced interventions, there will be a 30% reduction of unplanned hospital readmission risk in patients determined to be a medium-high risk of readmission (RecuR Score level 2 or 3). METHODS This is a parallel-group, two-arm, prospective, randomized, non-blinded, fallback design, controlled superiority study of the impact of a new transitional care model for patients determined to be at higher risk of 30-day unplanned hospital readmission conducted at UM CRMC. UM CRMC is an approximately 100-bed community hospital located in Charles County, Maryland and is part of the University of Maryland Medical System. Patients will be 1:1 (equally) randomized to Arm 1 or Arm 2 using a stratified randomization method with stratification by RecuR Score. Participants assigned to Arm 1 will receive the activities in Intervention "A" and the participants assigned to Arm 2 will receive the activities in Intervention "A" AND the activities in Intervention "B." As there is an apparent difference between Arm 1 and Arm 2, neither the patients nor providers will be blinded to the study assignment. Informed consent will be obtained and documented for this study. The target patient population is admitted patients (inpatients) at UM CRMC with a high readmission risk (RecuR Score) and/or specific admission diagnoses that are amenable to peri- and post-discharge interventions, where the goal is to reduce the readmission rate of this high-risk population. This study will use a fallback design with two primary endpoints. The first sequential primary endpoint is 30-day post-discharge unplanned hospital readmission in the overall study population. The second sequential primary endpoint is 30-day post-discharge unplanned hospital readmission in the medium-high risk population (RecuR Score 2 & 3). The significance level (0.05) will be divided evenly between the two primary endpoints, for a significance level of 0.025 for the first primary endpoint and a reserved 0.025 significance level for the second primary endpoint. DATA COLLECTION The patient's Electronic Health Record (EHR) from Epic will be the main source of information about the patient's demographics, admission diagnoses, length of stay, and outcomes data like subsequent hospital encounters in the 90 days post-discharge. The CRISP ("Chesapeake Regional Information System for our Patients") Admission Discharge Transfer (ADT) tool is the source that provides what hospital encounters the enrolled patients have post-discharge if they do not occur at UMMS facilities. DATA ANALYSIS As this is a fallback method design, we will first test the first primary endpoint against a 0.025 significance level. If the first test shows statistical significance, we will be able to add the unused alpha level from the first test to the reserved alpha level, for significance level of 0.05 to test the second primary endpoint. If this test fails to show statistical significance, we will proceed and test the second primary endpoint at the reserved 0.025 significance level. Patient characteristics will be summarized and compared between Arm 1 and Arm 2 for both the overall and RecuR Score 2 and 3 populations. Most results will be compared using a test of difference for two proportions. If the data are multi-categoric, the Mantel-Haenszel method will be used for comparisons. If an event is rare (<5%), the Fisher exact test will be used. Any continuous data will be compared using a t-test or Wilcoxon Rank Sum statistic. If data are greatly skewed, additional methods might be needed. These analyses will be used to present baseline and background characteristics, demonstrating that the analysis is balanced and representative of the general population, or pointing to areas where primary analyses might need to be adjusted to account for imbalances. All analyses of results for primary and secondary endpoints will be based on the Intent-to-Treat principle, where results are computed based on the Arm that the patient was randomized to rather than which interventions they actually received. All comparisons will be done for both the overall and medium-high risk study populations, assuming the study continues to the second primary endpoint. Comparison of hospital readmission will be performed using either z-tests, or Fischer's Exact test, depending on the rarity of the outcome of interest. If imbalances are noted in the baseline characteristics, adjusted regression models will be tested where indicated. Subgroup analysis will be performed, including a specific focus on differing readmission rates between the various RecuR Score risk levels.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Patient Readmission, Pulmonary Disease, Chronic Obstructive, Heart Failure, Diabetes Mellitus Poor Control, Hypertension, Pneumonia
Keywords
patient, unplanned, hospital, readmissions

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a two-arm interventional study where participants will be randomized to receive either the Standard of Care or Enhanced Care treatment. Participants in the Standard of Care arm will receive the Transitional Care protocol most commonly used for patients at the University of Maryland Charles Regional Medical Center (UM CRMC). Participants in the Enhanced Care arm will receive the interventions in the Standard of Care arm plus the additional protocols unique to Enhanced Care arm (Social Determinants of Health Wheel assessment in the University of Maryland Medical System electronic medical record, coordination of home health services, and additional diagnosis education). These arms are designed to ensure that participants receive the same high quality of care that they would have received before the study while also focusing on some added interventions from the enhanced care arm to help determine if these additional interventions help improve patient outcomes.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Arm 1: Intervention A
Arm Type
Active Comparator
Arm Description
Diagnosis education includes verbal 1:1 patient education by the Transitional Nurse Navigator (TNN) and a folder with Epic printed education and other handouts specific to that disease process. Follow-up appointment scheduling assistance, including transportation to the follow-up appointment. The Community Health Worker (CHW) or TNN will schedule the appointments for the PCP and other specialists within 1 week when available. Offer resources in the community post the 1:1 meeting with the patient to meet specific access to care challenges identified for that patient by the TNN or CHW. Provide weekly follow-up calls for one month by TNN or delegate. Social Determinants of Health (SDOH) assessment. Screenings by CHW regarding patients' SDOH and documentation in the EHR (Epic) of this SDOH assessment. If a patient demonstrates a need, a CHW will help identify and offer opportunities for the patient.
Arm Title
Arm 2: Receives Intervention "A" and Intervention "B"
Arm Type
Experimental
Arm Description
Additional educational training using iPads. Education using iPad and/or teach-back components to reinforce the individualized disease and medication specific education. iPads are programmed with patient education from "The Patient Channel." This visit will be completed by a TNN. Focus on readmission risk during Care Transition Rounds. Multi-disciplinary team conducts daily rounds to discuss patient. TNNs share the risk scores for the patients and discuss coordination of the patient receiving interventions and other resources suggested by team members. Home health care from Home Health Services (HHS), Mobile Integrated Healthcare (MIH) or Resources, Education and Access to Community Health (REACH). Involves home visits to the patient, environmental assessments, and medication reconciliation from a home health nurse. Duration and specifications of home health care depend on the patient's needs. Participants will be assigned based on program eligibility and availability.
Intervention Type
Other
Intervention Name(s)
Standard of Care
Other Intervention Name(s)
University of Maryland Medical System (UMMS) Charles Regional Medical Center (CRMC) Appendix A.1. Transitional Care/Nurse Navigator Program, Policy Number: 9770-001
Intervention Description
Diagnosis education. Follow-appointment scheduling assistance. Offer resources in the community. Offer weekly follow-up calls for one month. Social Determinants of Health (SDoH) assessment.
Intervention Type
Other
Intervention Name(s)
Enhanced Care
Intervention Description
Additional educational training using computer tablet devices, such as iPads. Focus on readmission risk. Set-up Home Health Services (HHS), Mobile Integrated Healthcare (MIH) or Resources, Education and Access to Community Health (REACH).
Primary Outcome Measure Information:
Title
Number of overall participants with 30-day post-discharge hospital readmission
Description
This is the first primary endpoint of this fallback design study. It measures the number of participants with a hospital readmission in the 30 days post-hospital discharge in the overall study population.
Time Frame
30 days post-hospital discharge
Title
Number of moderate-high risk participants with 30-day post-discharge hospital readmission
Description
This is the second primary endpoint of this fallback design study. It measures the number of moderate-high risk participants, those having a RecuR Score of 2 or 3, with a hospital readmission in the 30 days post-hospital discharge.
Time Frame
30 days post-hospital discharge
Secondary Outcome Measure Information:
Title
30 day post-discharge mortality
Description
Number of participants with 30 day post-discharge mortality
Time Frame
30 days post-hospital discharge
Title
30 day post-discharge unplanned hospital readmission
Description
Number of participants with 30 day post-discharge unplanned hospital readmission
Time Frame
30 days post-hospital discharge
Title
90-day post-discharge unplanned hospital readmission
Description
Number of participants with 90 day post-discharge unplanned hospital readmission
Time Frame
90 days post-hospital discharge
Title
30-day post-discharge emergency department usage
Description
Number of participants with 30 day post-discharge emergency department usage
Time Frame
30 days post-hospital discharge
Title
90-day post-discharge emergency department usage
Description
Number of participants with 90 day post-discharge emergency department usage
Time Frame
90 days post-hospital discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Patient is in Observation (and is expected to be admitted) or is admitted as an Inpatient Encounter. Consider eligible patients in any unit except Emergency Department. Patient has RecuR Score available 24 hours after start of data collection in EHR. Patient is at least 18 years of age. Participant is willing and able to provide informed consent for the trial. Participant has a RecuR Score greater than or equal to 3; OR Participant has a RecuR Score greater than or equal to 2 and length of stay greater than 10 days; OR Participant has a RecuR Score greater than or equal to 2 with admitting diagnosis of COPD, CHF, Diabetes with elevated HbA1c, Hypertension, or pneumonia; OR Participant has any RecuR Score AND current admission is a readmission where participant was not enrolled during any prior admission. Exclusion Criteria Patients who were enrolled in the pilot during an earlier inpatient hospital encounter. Patients with encounters having length of stay less than 48 hours or greater than 30 days. Patients who are not expected to be discharged to "home", e.g., patients who were admitted from skilled nursing facility (SNF) and are expected to be discharged to SNF. Use Admission Source (or disposition field) as an indicator of who may not be discharged home. Patients with an admission diagnosis of Septicemia. Patients who lack capacity to sign the consent and participate in the study. Patients who are not fluent English. Patients who are already receiving home health care. Patients who the nursing team believes will require home health care post- hospitalization. Post-Hoc Exclusion Criteria • Patients who leave against medical advice.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martina Miller, MS
Phone
410-706-3869
Email
martina.miller@umaryland.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Human Protections Administrator
Phone
410-706-5037
Email
hrpo@umaryland.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stephen N Davis, MBBS
Organizational Affiliation
University of Maryland, Baltimore
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Maryland Charles Regional Medical Center
City
La Plata
State/Province
Maryland
ZIP/Postal Code
20646
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary Hannah
Phone
301-609-4976
Email
mhannah@umm.edu

12. IPD Sharing Statement

Citations:
PubMed Identifier
3558716
Citation
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.
Results Reference
background
PubMed Identifier
28710226
Citation
Damery S, Combes G. Evaluating the predictive strength of the LACE index in identifying patients at high risk of hospital readmission following an inpatient episode: a retrospective cohort study. BMJ Open. 2017 Jul 13;7(7):e016921. doi: 10.1136/bmjopen-2017-016921.
Results Reference
background
PubMed Identifier
25268437
Citation
Dhalla IA, O'Brien T, Morra D, Thorpe KE, Wong BM, Mehta R, Frost DW, Abrams H, Ko F, Van Rooyen P, Bell CM, Gruneir A, Lewis GH, Daub S, Anderson GM, Hawker GA, Rochon PA, Laupacis A. Effect of a postdischarge virtual ward on readmission or death for high-risk patients: a randomized clinical trial. JAMA. 2014 Oct 1;312(13):1305-12. doi: 10.1001/jama.2014.11492.
Results Reference
background
PubMed Identifier
26954698
Citation
Donze JD, Williams MV, Robinson EJ, Zimlichman E, Aujesky D, Vasilevskis EE, Kripalani S, Metlay JP, Wallington T, Fletcher GS, Auerbach AD, Schnipper JL. International Validity of the HOSPITAL Score to Predict 30-Day Potentially Avoidable Hospital Readmissions. JAMA Intern Med. 2016 Apr;176(4):496-502. doi: 10.1001/jamainternmed.2015.8462.
Results Reference
background
PubMed Identifier
22007045
Citation
Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011 Oct 18;155(8):520-8. doi: 10.7326/0003-4819-155-8-201110180-00008.
Results Reference
background
PubMed Identifier
27065180
Citation
Jenq GY, Doyle MM, Belton BM, Herrin J, Horwitz LI. Quasi-Experimental Evaluation of the Effectiveness of a Large-Scale Readmission Reduction Program. JAMA Intern Med. 2016 May 1;176(5):681-90. doi: 10.1001/jamainternmed.2016.0833.
Results Reference
background
PubMed Identifier
31029692
Citation
Kripalani S, Chen G, Ciampa P, Theobald C, Cao A, McBride M, Dittus RS, Speroff T. A transition care coordinator model reduces hospital readmissions and costs. Contemp Clin Trials. 2019 Jun;81:55-61. doi: 10.1016/j.cct.2019.04.014. Epub 2019 Apr 25.
Results Reference
background
PubMed Identifier
24820131
Citation
Leppin AL, Gionfriddo MR, Kessler M, Brito JP, Mair FS, Gallacher K, Wang Z, Erwin PJ, Sylvester T, Boehmer K, Ting HH, Murad MH, Shippee ND, Montori VM. Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med. 2014 Jul;174(7):1095-107. doi: 10.1001/jamainternmed.2014.1608.
Results Reference
background
PubMed Identifier
34380667
Citation
Marafino BJ, Escobar GJ, Baiocchi MT, Liu VX, Plimier CC, Schuler A. Evaluation of an intervention targeted with predictive analytics to prevent readmissions in an integrated health system: observational study. BMJ. 2021 Aug 11;374:n1747. doi: 10.1136/bmj.n1747.
Results Reference
background
PubMed Identifier
30109585
Citation
McWilliams A, Roberge J, Anderson WE, Moore CG, Rossman W, Murphy S, McCall S, Brown R, Carpenter S, Rissmiller S, Furney S. Aiming to Improve Readmissions Through InteGrated Hospital Transitions (AIRTIGHT): a Pragmatic Randomized Controlled Trial. J Gen Intern Med. 2019 Jan;34(1):58-64. doi: 10.1007/s11606-018-4617-1. Epub 2018 Aug 14.
Results Reference
background
PubMed Identifier
20194559
Citation
van Walraven C, Dhalla IA, Bell C, Etchells E, Stiell IG, Zarnke K, Austin PC, Forster AJ. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010 Apr 6;182(6):551-7. doi: 10.1503/cmaj.091117. Epub 2010 Mar 1.
Results Reference
background
PubMed Identifier
25099997
Citation
Wang H, Robinson RD, Johnson C, Zenarosa NR, Jayswal RD, Keithley J, Delaney KA. Using the LACE index to predict hospital readmissions in congestive heart failure patients. BMC Cardiovasc Disord. 2014 Aug 7;14:97. doi: 10.1186/1471-2261-14-97.
Results Reference
background
Links:
URL
https://innovation.cms.gov/innovation-models/cctp#:~:text=The%20Community%2Dbased%20Care%20Transitions
Description
Community-based Care Transitions Program | CMS Innovation Center
URL
https://hcup-us.ahrq.gov/reports/statbriefs/sb246-Geographic-Variation-Hospital-Stays.pdf
Description
Overview of U.S. Hospital Stays in 2016: Variation by Geographic Region
URL
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program#:~:text=The%20Hospital%20Readmissions%20Reduction%20Program
Description
Hospital Readmissions Reduction Program (HRRP)
URL
https://hcup-us.ahrq.gov/reports/statbriefs/sb261-Most-Expensive-Hospital-Conditions-2017.jsp
Description
National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2017
URL
https://hcup-us.ahrq.gov/reports/statbriefs/sb278-Conditions-Frequent-Readmissions-By-Payer-2018.pdf
Description
Overview of Clinical Conditions With Frequent and Costly Hospital Readmissions by Payer, 2018

Learn more about this trial

UM CRMC RecuR Score Pilot

We'll reach out to this number within 24 hrs